The disclaimer for the EAHP COVID-19 Resource Centre can be found here [203]
Links
[1] https://www.alzheimer-europe.org
[2] https://www.aasld.org/sites/default/files/2020-04/AASLD-COVID19-ClinicalInsights-4.07.2020-Final.pdf
[3] https://www.aasld.org/sites/default/files/2021-03/AASLD-COVID19-ExpertPanelConsensusStatement-March92021.pdf
[4] http://www.nutritioncare.org/Guidelines_and_Clinical_Resources/Enteral_Nutrition_Resources/
[5] http://www.nutritioncare.org/PNResources/
[6] https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/Nutrition%20Therapy%20COVID-19_SCCM-ASPEN.pdf
[7] https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/covid-19/covidtaskforce.pdf
[8] https://cdn.ymaws.com/www.ascp.com/resource/resmgr/docs/disaster/field_guide_to_reduce_medica.pdf
[9] https://cdn.ymaws.com/www.ascp.com/resource/resmgr/docs/disaster/covid-19__sars-cov-2__pandem.pdf
[10] https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx
[11] https://www.eahp.eu/sites/default/files/ctools/ashp-covid-19-evidence-table-03-21-20.pdf
[12] https://www.interactivehandbook.com/Authentication/Authentication.aspx
[13] https://www.thoracic.org/covid/covid-19-guidance.pdf
[14] https://www.aepc.org/covid-19-q-a
[15] https://apmonline.org/wp-content/uploads/2020/04/priority-meds-for-end-of-life-care-290420-final-2.pdf
[16] https://static1.squarespace.com/static/5e6613a1dc75b87df82b78e1/t/5e999ad41f79016c41a07d9b/1587125084445/COVID-19+POTENTIAL+ANAESTHETIC+DRUG+LIST
[17] https://static1.squarespace.com/static/5e6613a1dc75b87df82b78e1/t/5f68ce9ccda1805270405136/1600704156814/Second-Surge-Guidance.pdf
[18] https://anaesthetists.org/Home/Resources-publications/COVID-19-guidance/Tips-information-and-innovation-COVID-19/Clinician-tips-for-COVID-19
[19] https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.15358
[20] https://cdn.ymaws.com/www.theabn.org/resource/collection/65C334C7-30FA-45DB-93AA-74B3A3A20293/ABN_Guidance_on_DMTs_for_MS_and_COVID19_05_Nov_2020.pdf
[21] https://www.ogp.at/wp_ogp/wp-content/uploads/ÖGP-Statement-zu-COVID_final_IC.pdf
[22] https://www.ogp.at/wp_ogp/wp-content/uploads/Update-SARS-CoV-2-Behandlungsempfehlungen-f....pdf
[23] https://www.apb.be/APB%20Documents/FR/All%20partners/CORONAVIRUS_INTERACTIONS_CHLOROQUINE_HYDROXYCHLOROQUINE.pdf
[24] https://www.apb.be/fr/corp/sante-publique/Info-Corona/Recommandations-questions-scientifiques/Pages/traitements-hospitaliers.aspx
[25] http://www.siz.be/wp-content/uploads/IZ-protocol-COVID19-Kortrijk.pdf
[26] https://www.bad.org.uk/healthcare-professionals/covid-19
[27] https://www.bad.org.uk/healthcare-professionals/covid-19/covid-19-immunosuppressed-patients
[28] https://www.bad.org.uk/shared/get-file.ashx?itemtype=document&id=6888
[29] https://www.bad.org.uk/shared/get-file.ashx?itemtype=document&id=6659
[30] https://www.bccsu.ca/wp-content/uploads/2020/05/COVID-19-Bulletin-May-20-2020.pdf
[31] https://www.bccsu.ca/wp-content/uploads/2020/05/COVID-19-Bulletin-AUD-v2.pdf
[32] http://www.bcca-uk.org/documents/my_files/COVID_BCCA_Vulnerable_groups_FINAL-18_March_2020.pdf
[33] https://www.bgs.org.uk/resources/coronavirus-managing-delirium-in-confirmed-and-suspected-cases
[34] https://www.bgs.org.uk/resources/covid-19-and-medicines-advice-for-older-people
[35] https://www.bhiva.org/file/5f56057450cc3/BHIVA-interim-ART-guidelines-COVID-19.pdf
[36] https://b-s-h.org.uk/media/19590/guidance-version-17-on-mngmt-of-vitt-20210420.pdf
[37] https://b-s-h.org.uk/media/19241/clinician-faqs-and-guidance-on-covid19-vaccine-for-patients-receiving-sa_.pdf
[38] https://www.immunology.org/sites/default/files/BSI_Ageing_COVID-19_Report_Nov2020_FINAL.pdf
[39] https://cdn.ymaws.com/www.bnms.org.uk/resource/resmgr/news_&_press_office/news/new_110161_nuclear_medicine_.pdf
[40] https://www.bsg.org.uk/covid-19-guidance-advice-documents/
[41] https://www.bsg.org.uk/covid-19-advice/covid-19-hepatology-advice/bsg-best-practice-document-hepatocellular-carcinoma-hcc-surveillance-during-the-covid-19-pandemic/
[42] https://bspghan.org.uk/wp-content/uploads/2020/04/COVID_IBDWG_HCP.pdf
[43] https://www.bsrm.org.uk/downloads/2020.06.23--icsframework-for-assessing-early-reha-(1).pdf
[44] https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/bts-guidance-on-venous-thromboembolic-disease-in-patients-with-covid-19/
[45] https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/spaces-information-document/
[46] https://www.eahp.eu/sites/default/files/ctools/ppe-best-practice-suggestions.pdf
[47] https://www.pharmacists.ca/advocacy/covid-19-information-for-pharmacists/
[48] https://www.youtube.com/watch?v=MFLre9Rqnjs&list=UUiXPPfsm-fgKbqDGICou7aA
[49] https://www.entcanada.org/wp-content/uploads/Protocol-for-COVID-and-AGMP-3-iw-mailer.pdf
[50] https://www.eahp.eu/sites/default/files/ctools/cpa-coronavirus-2019-ncov-expert-consensus-on-guidance-and-prevention_0.pdf
[51] https://www.eahp.eu/sites/default/files/ctools/english_sars-cov-2_infection_expert_consensus_on_guidance_and_prevention_and_control_strategies_for_retail_pharmacy_workforce.pdf
[52] https://www.cmei.org.cn/content/?15429.html
[53] https://www.chinalawtranslate.com/en/coronavirus-treatment-plan-7/
[54] https://www.eahp.eu/sites/default/files/disinfectant_for_hand_hygiene_.pdf
[55] https://nvza.nl/nvza/nvza-en-covid-19/
[56] https://www.demedischspecialist.nl/onderwerp/details/richtlijnen-handreikingen-leidraden
[57] https://www.sfk.nl/publicaties/productnieuws/patientenlijst-covid-19-vaccinaties
[58] https://www.entuk.org/sites/default/files/files/ENT_UK_COVID_19_tonsillitis_and_quinsy_guidelines.pdf
[59] https://www.entuk.org/guidance-undertaking-otological-procedures-during-covid-19-pandemic-0
[60] https://www.entuk.org/sites/default/files/BRS%20COVID%20anosmia%20guidelines%20-%20recommendations%20only.pdf
[61] https://www.entuk.org/sites/default/files/A%20Graduated%20Return%20to%20Elective%20ENT%20within%20the%20COVID%2C%20new%20version.pdf
[62] https://eadv.org/covid-19/task-force
[63] https://www.eadv.org/cms-admin/showfile/4_ERN-Skin%20%C2%A0recommendations%20for%20patients%20with%20rare%20skin%20disease%20during%20the%20COVID-19%20virus%20pandemic.pdf
[64] https://easl.eu/wp-content/uploads/2020/04/EASL-ESCMID-Position-Paper-on-COVID-19-and-the-liver-2-April-2020.pdf
[65] https://www.ecfs.eu/covid-cf-project-europe
[66] https://ehaweb.org/covid-19/covid-19-recommendations/
[67] https://europeanpainfederation.eu/efic-pain-research/covid-19/
[68] https://www.europsy.net/app/uploads/2020/04/ALGORITHM-Hospitalisation-COVID_EPA.pdf
[69] https://www.era-edta.org/en/wp-content/uploads/2020/03/COVID_guidelines_finale_eng-GB.pdf
[70] https://www.ebmt.org/sites/default/files/2020-03/SAAWP_COVID_Recommendations.pdf
[71] https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic?hit=ehp
[72] https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang
[73] https://www.escardio.org/Education/COVID-19-and-Cardiology/chloroquine-and-cardiovascular-side-effects
[74] https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance?hit=home&urlorig=/vgn-ext-templating/
[75] https://www.escmid.org/fileadmin/src/media/PDFs/3Research_Projects/ESGLI/ESGLI_Guidance_for_managing_Legionella_in_hospital_water_systems_during_COVID__19_20200603_v_03_00.pdf
[76] https://www.esicm.org/blog/wp-content/uploads/2020/03/SSC-COVID19-.pdf
[77] https://www.einfach-unverzichtbar.de/informationen-zu-corona/
[78] http://splf.fr/wp-content/uploads/2020/04/RespiPreREA-SPLF-GAVO2avril2020-english-version-r.pdf
[79] http://splf.fr/wp-content/uploads/2020/04/COVID-asthma_CRISALIS-EN.pdf
[80] https://www.srlf.org/wp-content/uploads/2020/03/Recommandations-dexperts-COVID-19-10-Mars-2020.pdf
[81] https://sfar.org/download/traitement-anticoagulant-pour-la-prevention-du-risque-thrombotique-chez-un-patient-hospitalise-avec-covid-19-et-surveillance-de-lhemostase/?wpdmdl=25834&refresh=5e89aef9a9e391586081529
[82] https://sfar.org/prevention-des-erreurs-medicamenteuses-en-anesthesie-et-en-reanimation-kit-pedagogique/
[83] https://sfar.org/covid-19/
[84] http://sfpc.eu/covid/
[85] https://splf.fr/wp-content/uploads/2021/02/SFHH-Avis-relatif-aux-mesures-hygiene-pour-la-prise-en-charge-un-patient-ou-resident-considere-comme-cas-possible-probable-ou-confirme-d-infection-SARS-CoV-2-12-01-21.pdf
[86] https://www.sfpo.com/wp-content/uploads/2020/04/Recommandations-SFPO-Pand%C3%A9mie-COVID.pdf
[87] https://ascopubs.org/doi/10.1200/OP.20.00295
[88] https://sfpt-fr.org/covid19-foire-aux-questions
[89] https://sfpt-fr.org/images/documents/STP/Recommandations_STP_ANRS_AC43_Pharmacologie_v2_26_03_20.pdf
[90] https://www.em-consulte.com/em/covid-19/AINS-COVID19.pdf
[91] https://splf.fr/wp-content/uploads/2021/03/bamlanivimab_communique_de_presse_SFPT-01-03-21.pdf
[92] https://www.hug-ge.ch/sites/interhug/files/structures/coronavirus/documents/hydroxy-chloroquine_et_covid-19.pdf
[93] https://www.hug.ch/sites/interhug/files/structures/coronavirus/documents/corticosteroides-et-covid-19.pdf
[94] https://www.adka.de/
[95] https://www.awmf.org/uploads/tx_szleitlinien/113-001l_S3_Empfehlungen-zur-stationaeren-Therapie-von-Patienten-mit-COVID-19__2021-02.pdf
[96] https://pneumologie.de/fileadmin/user_upload/COVID-19/2020-03-30_Rec_Covid-19_Palliativ-2_en.pdf
[97] http://gbs-vbs.org/fileadmin/user_upload/Unions/PED/Belg_Recomm_COVID_ped_31mar_FR.pdf
[98] https://eody.gov.gr/wp-content/uploads/2020/04/covid19-algorithm-16-4-2020.pdf
[99] http://www.hts.org.gr/assets/2nd%20argorithm.gif
[100] https://www.idstewardship.com/coronavirus-covid-19-resources-pharmacists/
[101] https://www.icmr.gov.in/pdf/covid/techdoc/Guidance_for_Management_of_Pregnant_Women_in_COVID19_Pandemic_12042020.pdf
[102] https://rcpi-live-cdn.s3.amazonaws.com/wp-content/uploads/2021/05/COVID19-pregnancy-040521.pdf
[103] http://www.interaccionesvih.com/docs/Interacciones%20importantes%20con%20Kaletra,%20Hidroxicloroquina%20y%20Remdesivir_3_junio_2020_COVID_19_.pdf
[104] http://www.interaccionesvih.com/docs/Interacciones%20importantes_TAR_COVID_19.pdf
[105] https://www.theisn.org/initiatives/covid-19/
[106] https://www.guidetopharmacology.org/coronavirus.jsp
[107] https://www.eahp.eu/sites/default/files/covid-19_bulletin_umpc.pdf
[108] https://www.eahp.eu/sites/default/files/covid-19_linee_guida_trattamento.jpg
[109] https://www.eahp.eu/sites/default/files/tocilizumab.pdf
[110] https://www.lice.it/pdf/Antiepileptic_drugs_interactions_in_COVID-19_01.04.pdf
[111] https://www.lice.it/pdf/Tabella_interazioni_Antiepilettici_in_COVID-19_30.03.pdf
[112] https://www.eahp.eu/sites/default/files/i.o._antiretroviralisifo-sifap_rev01_18.03.2020_senzatraccia_updated.pdf
[113] https://www.sifoweb.it/sifo-covid-19-link.html
[114] https://www.sifoweb.it/images/news-allegati/I.O.sospensioniRezolstaRev.00_26.03.2020_ok.pdf
[115] https://www.sifoweb.it/images/pdf/IO_IDROSSICLOROCHINA_Rev.00_16.04.2020.pdf
[116] https://www.sifoweb.it/images/Istruzione_operativa_Rev.00_DPI_Coronavirus_20.04.2020.pdf
[117] https://www.sifoweb.it/images/pdf/attivita/attivita-scientifica/aree_scientifiche/Area_galenica/IstruzioneOperativaSiringhe_05.02.2021_Rev00_copia.pdf
[118] https://www.eahp.eu/sites/default/files/linee_guida_sulla_gestione_terapeutica_e_di_supporto_per_pazienti_con_infezione_da_coronavirus_covid-19.pdf
[119] https://www.eahp.eu/sites/default/files/covid19_vademecum_2.0_13_marzo_2020.03_11.pdf
[120] https://www.simit.org/images/news/1588-flow-chart-gestionale-terapia-domiciliare-precoce-covid-19-versione-27-marzo-2020.pdf
[121] https://www.simit.org/images/documenti/therapeutic%20strategies%20sIMIT.pdf
[122] https://www.eahp.eu/sites/default/files/sifap_newsletter_26_febbraio_2020.pdf
[123] https://rega.kuleuven.be/if/pdf_corona
[124] http://www.covid19-druginteractions.org/
[125] http://www.med.umich.edu/asp/pdf/adult_guidelines/COVID-19-treatment.pdf
[126] https://www.nccn.org/covid-19/pdf/COVID_Infections.pdf
[127] https://www.nccn.org/docs/default-source/covid-19/2021_covid-19_vaccination_guidance_v2-0.pdf?sfvrsn=b483da2b_2
[128] https://www.nccn.org/docs/default-source/covid-19/2021-covid-infectious-disease-management.pdf?sfvrsn=63f70c30_7
[129] https://www.palliativecareguidelines.scot.nhs.uk/guidelines/symptom-control/end-of-life-care-guidance-when-a-person-is-imminently-dying-from-covid-19-lung-disease.aspx
[130] https://www.palliativecareguidelines.scot.nhs.uk/guidelines/symptom-control/alternatives-to-regular-medication-normally-given-via-a-syringe-pump-when-this-is-not-available.aspx
[131] https://www.sps.nhs.uk/category/covid-19-coronavirus/
[132] https://www.sps.nhs.uk/articles/lithium-drug-monitoring-in-primary-care-during-covid-19-for-stable-patients/
[133] https://www.sps.nhs.uk/articles/drug-packaging-and-labelling-during-covid-19-poster-and-screensaver-for-teams/
[134] https://www.sps.nhs.uk/articles/care-homes-clinical-pharmacy/
[135] https://www.sps.nhs.uk/articles/dexamethasone-and-covid-19/
[136] https://www.sps.nhs.uk/home/covid-19-vaccines/
[137] https://www.awmf.org/uploads/tx_szleitlinien/113-001LGl_S3_Empfehlungen-zur-stationaeren-Therapie-von-Patienten-mit-COVID-19__2021-05.pdf
[138] https://physicians.northernhealth.ca/sites/physicians/files/physician-resources/covid-19/COVID-19-end-of-life-symptom-management-algorithm.pdf
[139] https://physicians.northernhealth.ca/sites/physicians/files/physician-resources/covid-19/medication-conservation-strategies.pdf
[140] https://splf.fr/wp-content/uploads/2021/03/COREB-COVID-19en-EHPAD-reperer-et-prendre-en-charge-11-03-21.pdf
[141] https://www.coreb.infectiologie.com/fr/covid-19-prise-en-charge-et-suivi-du-patient-en-medecine-de-ville.html
[142] http://www.ordre.pharmacien.fr/Les-pharmaciens/Champs-d-activites/Covid-19
[143] https://picsociety.uk/wp-content/uploads/2020/04/Paediatric-Critical-Care-alternative-medicines-v1.0.pdf
[144] https://www.fip.org/files/content/priority-areas/coronavirus/mo-resources/Serbia_InterimGuidanceOnSARSCoV2.pdf
[145] https://www.eahp.eu/sites/default/files/operating_instruction_lopinavir_400_ritonavir_100_powder_for_oral_suspension.pdf
[146] https://www.fip.org/files/content/priority-areas/coronavirus/mo-resources/PORTUGAL_Hospital_pharmacy_recommendations_APFH.pdf
[147] https://www.ordemfarmaceuticos.pt/fotos/editor2/2019/WWW/campanhas/coronavirus/PlanoFH.pdf
[148] https://www.ordemfarmaceuticos.pt/pt/campanhas/coronavirus/
[149] https://www.fip.org/files/content/priority-areas/coronavirus/mo-resources/Portugal_Actions_against_COVID_OF_and_ANF.pdf
[150] https://www.sppneumologia.pt/uploads/subcanais_conteudos_ficheiros/recomendacoes-da-spp-no-diagnostico-e-no-tratamento-de-doencas-difusas-do-pulmao-durante-a-pandemia-por-sars-cov-2.pdf
[151] https://pcpa.org.uk/covid.html
[152] https://www.rcr.ac.uk/sites/default/files/melanoma-treatment-covid19.pdf
[153] https://www.rcr.ac.uk/sites/default/files/oncology_ppe_poster_a3.pdf
[154] https://www.rcem.ac.uk/docs/Policy/ED-AM%20%20Vaccine%20pathway%20concerns%20-%20RCP%20-%20SAM%20-%20RCEM.pdf%20recommendations
[155] https://www.rcgp.org.uk/covid-19/latest-covid-19-guidance-in-your-area.aspx#workload
[156] https://elearning.rcgp.org.uk/pluginfile.php/149457/mod_page/content/54/Symptom%20management%20using%20non-oral%20non-parenteral%20routes%20of%20admin_FINAL_200920.pdf
[157] https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-pregnancy/
[158] https://www.rcog.org.uk/globalassets/documents/guidelines/2020-08-10-occupational--health--advice--for--employers-and--pregnant-women-during-the-covid-19-pandemic.pdf
[159] https://www.rcog.org.uk/globalassets/documents/guidelines/2020-11-23-guidance-for-fetal-medicine-units.pdf
[160] https://www.rcpch.ac.uk/resources/covid-19-clinical-management-children-admitted-hospital-suspected-covid-19
[161] https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf
[162] https://www.rcpch.ac.uk/resources/covid-19-guidance-acute-settings
[163] https://www.rcpch.ac.uk/resources/covid-19-guidance-clinically-extremely-vulnerable-children-young-people
[164] https://www.rcpch.ac.uk/resources/national-guidance-management-children-bronchiolitis-during-covid-19
[165] https://www.rcplondon.ac.uk/news/risk-assessments-staff-priority-prevent-further-deaths-and-covid-specific-research-needed
[166] https://www.rcplondon.ac.uk/file/26276/download
[167] https://www.rcpsych.ac.uk/about-us/responding-to-covid-19/responding-to-covid-19-guidance-for-clinicians
[168] https://about.medicinescomplete.com/publication/critical-illness?utm_source=EAHP_WEB&utm_medium=WEB&utm_campaign=CI_APR20
[169] https://www.rpharms.com/coronavirus
[170] https://epidemio.wiv-isp.be/ID/Documents/Covid19/COVID-19_InterimGuidelines_Treatment_ENG.pdf
[171] https://mcusercontent.com/e11f8fc83cbbb714881d3030b/files/a7e79d4d-4e3d-458a-b54c-e0d82ca34877/Guidelines_on_contingency_planning_for_people_who_use_drugs_and_COVID_19_Version_1.pdf
[172] https://splf.fr/wp-content/uploads/2021/02/Society-of-breast-imaging-Recommendations-for-the-Management-of-Axillary-Adenopathy-in-Patients-with-Recent-COVID-19-Vaccination-Mis-en-ligne-par-la-Societe-francaise-de-radiologie-le-10-02-21.pdf
[173] https://sidp.org/covid19
[174] https://www.surgonc.org/wp-content/uploads/2020/03/Breast-Resource-during-COVID-19-3.30.20.pdf
[175] https://www.surgonc.org/wp-content/uploads/2020/03/Colorectal-Resource-during-COVID-19-3.30.20.pdf
[176] https://www.surgonc.org/wp-content/uploads/2020/03/Endocrine-Head-and-Neck-Resource-during-COVID-19-3.30.20.pdf
[177] https://www.surgonc.org/wp-content/uploads/2020/03/GI-and-HPB-Resource-during-COVID-19-3.30.20.pdf
[178] https://www.surgonc.org/wp-content/uploads/2020/03/Melanoma-Resource-during-COVID-19-3.30.20.pdf
[179] https://www.surgonc.org/wp-content/uploads/2020/03/PSM-Resource-during-COVID-19-3.23.20.pdf
[180] https://www.surgonc.org/wp-content/uploads/2020/03/Sarcoma-Resource-during-COVID-19-3.30.20.pdf
[181] http://www.ismp-espana.org/ficheros/Boletin%2049%20%28Abril%202020%29.pdf
[182] https://www.aeped.es/sites/default/files/protocolo_seip_aep_secip_trata_miento_especifico_21.03.20.pdf
[183] https://www.aeped.es/sites/default/files/b26-11-_aep-seip-secip-seup._documento_de_manejo_clinico_del_paciente_pediatrico.pdf
[184] https://secardiologia.es/images/secciones/insuficiencia/Implicaciones_de_la_pandemia_por_COVID-19_para_el_paciente_con_insuficiencia_cardiaca_trasplante_cardiaco_y_asistencia_ventricular.pdf
[185] https://semg.es/images/2020/Coronavirus/kit_covid_peresistente_ingles.pdf
[186] https://www.segg.es/media/descargas/farmacologia-trastornos-psicoticos-mayores-covid-19.pdf
[187] https://www.eahp.eu/sites/default/files/hospital_pharmacy_procedures_covid-19_march19th.pdf
[188] https://www.sefh.es/fichadjuntos/RESUMENINTERACCIONESCOVID19asma.pdf
[189] https://www.sefh.es/fichadjuntos/Sociedadesconjuntodef.6_4_2020.pdf.pdf
[190] https://www.sefh.es/fichadjuntos/Desinfeccion-limpieza-Farmacotecnia-COVID19.pdf
[191] http://www.secpal.com//Documentos/Blog/2020_03_23%20FIN%20DE%20VIDA%20Y%20COVID%2019%20_1.%20Documento%20para%20profesionales_1.pdf
[192] https://www.covid-19.seth.es/recomendaciones-de-tromboprofilaxis-y-tratamiento-antitrombotico-en-pacientes-con-covid-19/
[193] https://thrombosisuk.org/downloads/T&H%20and%20COVID.pdf
[194] https://covid19.teb.org.tr
[195] https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Coronavirus/Introduction%20to%20Critical%20Care%20COVID19%20FINAL%20version%203%20(002).pdf?ver=2020-04-03-162421-743
[196] https://www.eahp.eu/sites/default/files/covid-19_therapeutic_options_v1_dutch.pdf
[197] https://www.eahp.eu/sites/default/files/covid-19_therapeutic_options_v1_dutch.pptx
[198] https://www.birmingham.ac.uk/university/colleges/mds/Coronavirus/COVID-19-research-briefing.aspx
[199] https://vascern.eu/home/vascerns-covid19-recommendations/
[200] https://www.eahp.eu/sites/default/files/vkvsk_covid_.pdf
[201] https://www.wfsahq.org/images/Guidance_on_COVID-19_and_anaesthesia.pdf
[202] https://www.wfsahq.org/components/com_virtual_library/media/d8c7222bda2c4cb1b4c44255620add72-atow-426-01.pdf
[203] https://www.eahp.eu/hp-practice/hospital-pharmacy/eahp-covid-19-resource-centre